Public awareness campaign that focuses on the treatments currently under development by pharmaceutical companies


“Illness never sleeps, so neither do we”: the strapline of this campaign testifies to the tireless commitment of pharmaceutical companies to combat disease. Adapted from a pan-European campaign launched by the European Federation of Pharmaceutical Industries and Associations (EFPIA) this initiative is a direct response to the expressed need by the public for information on the current status of research into new treatments.

Key figures on the research conducted by pharmaceutical companies


·         7,000 new medicines currently in development

·         Cancer: 1,800 new medicines in development

·         3 million lives saved worldwide each year thanks to vaccines

·         AIDS: 160 new medicines in development

·         Heart diseases: 600 new medicines in development

·         Diabetes: 475 new medicines in development

·         Eczema, psoriasis: 277 new medicines in development

·         Rare diseases: 567 new medicines in development

·         Alzheimer’s and Parkinson’s disease: 1,300 new medicines in development

·         Hepatitis C: over 95% of treated patients recover. 29 new medicines in development


Download banners size: 728×90

Download banners size: 300×250

To view EFPIA’s campaign We Won’t Rest follow the link: